Narrative review / 2008
Atypical parkinsonism in Guadeloupe was linked to regular soursop consumption, with annonacin implicated as a potential etiological factor.
In Guadeloupe, atypical parkinsonian patients comprise two-thirds of all parkinsonism cases, presenting with levodopa-resistant parkinsonism, tremor, myoclonus, hallucinations, REM sleep behavior disorder, and fronto-subcortical dementia. Epidemiological data suggested a close association between the condition and regular consumption of soursop. Experimental midbrain cell culture studies identified annonacin, a mitochondrial complex I inhibitor in soursop, as a probable etiological factor, and chronic annonacin administration reproduced characteristic brain lesions in rats.
Shows an association, not proof of cause and effect.
- Study type
- Narrative review
- Who was studied
- Patients with atypical parkinsonism in Guadeloupe
- What was measured
- Etiology of atypical parkinsonism and association with soursop/annonacin
THE PAPER
Atypical parkinsonism in the Caribbean island of Guadeloupe: etiological role of the mitochondrial complex I inhibitor annonacin.
Lannuzel A, Ruberg M, Michel PP. Mov Disord, 2008.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.